Strong dollar dampens Baxter's first-quarter sales
This article was originally published in Clinica
Executive Summary
Baxter saw sales rise 11% to $1,443 million in the first quarter. Excluding the effect of the strong dollar, the increase would be 13%. The company's sales outside the US rose 17% to $765 million - representing 53% of total sales. Baxter experienced strong growth in Latin America and Asia, the company's fastest-growing markets.